Article Text

Download PDFPDF

Connecting the dots: a story of unknown fever, acute coronary syndrome and pan-aortitis—an occult relapse of a large vessel vasculitis
  1. Abuelmagd Abdalla1,
  2. Imran Ali1,
  3. David Murphy2 and
  4. Eamonn Molloy1
  1. 1 Rheumatology Department, St. Vincent’s University Hospital, Dublin, Ireland
  2. 2 Radiology Department, St. Vincent’s University Hospital, Dublin, Ireland
  1. Correspondence to Dr Abuelmagd Abdalla, dr_abuelmagd{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


A 76-year-old woman presented to our emergency department with acute chest pain. She has a history of giant cell arteritis (GCA) 2 years previously which was successfully treated and weaned off steroids 14 months later. On arrival, her physical examination was unremarkable with no suggestion of sepsis. She was found to have dynamic ECG changes and borderline positive troponin T. A provisional impression of unstable angina was outlined and scheduled for a coronary angiogram the following day, which showed minor atheroma without obstruction.

Her labs revealed elevated inflammatory markers and normochromic normocytic anaemia. Full septic screening and autoimmune profile were negative. She was noted to have night sweats and fever up to 39°C the following few days. The patient’s chest pain did not improve and she continued to be febrile for the next week in the hospital with no cause revealed by subsequent investigations and infectious disease consultation.

At this point, a consult to rheumatology was made for an underlying unknown systemic illness. She admitted being relatively unwell for the recent 6 weeks with ongoing night sweats for the past 6 months but denied any specific GCA or Polymyalgia Rheumatica (PMR) symptoms. On review of medical history, her GCA diagnosis at the time was based on somehow a similar presentation of an unknown febrile systemic illness but accompanied by bilateral temporal headaches with a weakly palpable right temporal artery (TA). Her temporal biopsy showed no arterial tissue. However, as she was otherwise satisfying the American College of Rheumatology (ACR) 1990 GCA criteria,1 she was managed as such with good response and recovery.

This time, her TA ultrasound revealed a positive ‘halo’ sign (figure 1) on the left side suggesting a possibly active GCA. She then had CT angiogram of her aorta and major branches which showed diffuse thickening of the thoracic and abdominal aorta. Hybrid 18 F-fluorodeoxyglucose positron emission tomography/CT (FDG-PET/CT) scan revealed increased vascular FDG uptake throughout her thoracoabdominal aorta, bilateral subclavian, proximal carotids and axillary arteries (figures 2  and 3). The patient received 1 g of intravenous methylprednisolone for 3 days followed by oral prednisolone 60 mg/day with a satisfactory response to symptoms, fever and inflammatory markers. Given the nature of this serious relapse, ustekinumab was added on 2 months later. At 6 months, she remained in remission and her prednisolone reduced to 5 mg/day.

Figure 1

Colour Doppler ultrasound image shows circumferential hypoechoic wall oedema (arrowhead) of the superficial temporal artery, known as ‘Halo’ sign.

Figure 2

Coronal maximum intensity projection positron emission tomographic image showing the diffuse arterial uptake greater than background liver activity in the thoracic aorta, subclavian/axillary arteries and both proximal carotids (arrowheads).

Figure 3

Coronal (left) and sagittal (right) fused fluorodeoxyglucose positron emission tomographic/CT images highlighting the diffuse increased vascular wall uptake of the ascending and descending thoracic aorta (yellow arrowheads), subclavian/axillary arteries (blue arrowheads) and proximal common carotid arteries (red arrowheads).

There is no single diagnostic test for GCA. The diagnosis is based on a combination of compatible clinical, laboratory and imaging findings with/without TA biopsy. ACR 1990 GCA criteria do not include imaging. Although it remains the gold standard, the yield of TA biopsy for diagnosis is low.2 CT or magnetic resonance angiography is useful in delineating the vascular wall abnormalities, but they do not indicate disease activity, as does FDG-PET/CT.3 The latter is also useful in multiterritorial or occult disease.4 In a recent meta-analysis, hypoechoic halo on TA ultrasound is shown to have better sensitivity than biopsy,5 and when used concomitantly, it can add significantly to the diagnostic yield.6 This case highlights the dilemma of arriving at GCA diagnosis in practice, often by combining all the above tests.

Learning points

  • Giant cell arteritis (GCA) is the commonest vasculitis in the elderly population with serious vascular morbidities including aneurysms, irreversible sight loss and strokes. Therefore, it should be considered in the differential of an occult systemic illness or unknown fever.

  • Fluorodeoxyglucose positron emission tomography/CT has a pivotal role in revealing disease activity in atypical cases or multivascular territory involvement.

  • GCA is a challenging diagnosis in many numbers of cases with a high rate of variability in all the tests used and can strongly depend on the local access and expertise.


’Connecting the dots' was inspired by Steve Jobs' renowned commencement address at Stanford University 2005. ’You cannot connect the dots looking forward, you can only connect them looking backward'.


  1. 1.
  2. 2.
  3. 3.
  4. 4.
  5. 5.
  6. 6.


  • Contributors AA and IA are the Registrars directly involved in patient care, EM is the attending rheumatologist and DM is the reporting radiologist.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Patient consent for publication Obtained.